The current state of endovascular intervention for critical limb ischemia
Vascular Investigation and Therapy · 2021
DOI: 10.4103/2589-9686.313805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Investigation and Therapy, 2021. Verfasst von Hongxiao Wu und 5 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
The treatment of critical limb ischemia (CLI) has long been a “hot spot” in medical science. It is widely believed that revascularization is the cornerstone of CLI therapy. However, there is currently no consensus on the best revascularization approach. Traditional open surgery is traumatic and associated with many complications. In recent years, great progress has been witnessed in terms of endovascular technology, gradually replacing open surgery in the treatment of CLI. In this review, the role of endovascular therapies in clinical practice, including conventional percutaneous transluminal angioplasty, bare-metal stent, and innovated drug-coated balloon, drug-eluting stent, bioresorbable vascular scaffold, cutting balloon angioplasty, atherectomy, intravascular lithotripsy, cryoplasty, and percutaneous deep venous arterialization is discussed.
Zitieren
APA
Wu, H., Ye, P., Chen, Y., Li, Y., Cai, C., & Lv, P. (2021). The current state of endovascular intervention for critical limb ischemia. Vascular Investigation and Therapy. https://doi.org/10.4103/2589-9686.313805
Vancouver
Wu H, Ye P, Chen Y, Li Y, Cai C, Lv P. The current state of endovascular intervention for critical limb ischemia. Vascular Investigation and Therapy. 2021. doi:10.4103/2589-9686.313805
BibTeX
@article{Wu2021,
author = {Wu, Hongxiao and Ye, Pin and Chen, Yunfei and Li, Yiqing and Cai, Chuanqi and Lv, Ping},
title = {The current state of endovascular intervention for critical limb ischemia},
journal = {Vascular Investigation and Therapy},
year = {2021},
doi = {10.4103/2589-9686.313805}
}
EUVIMED